Ovation Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Focusing on unmet needs in CNS and oncology, Ovation Pharmaceuticals Inc. will acquire marketed drugs and late-stage candidates that don't represent a big enough payoff to their current manufacturers. The company plans to boost its acquisitions' value by developing new dosages, new formulations and new treatment indications, then add creative sales and marketing muscle to bring its products to the light of day.